A randomized phase 2 trial in Nature Medicine demonstrates that combining durvalumab immunotherapy with stereotactic radiation produces encouraging clinical responses in early-stage hormone-receptor-positive breast cancer, including patients with PD-L1-negative tumors. — Photo by Logan Gutierrez on Unsplash (Unsplash License)
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.
